Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | -3.43% | +14.67% | +204.42% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+204.42% | 321M | |
+29.30% | 682B | |
+30.83% | 586B | |
-3.20% | 364B | |
+17.67% | 327B | |
+4.10% | 285B | |
+16.38% | 240B | |
+9.97% | 209B | |
-8.67% | 203B | |
+7.54% | 165B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Transcript : Nektar Therapeutics - Shareholder/Analyst Call